glucagon receptor raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-01-09. Anything still debated is marked as such rather than presented as settled.
Receptor activation produces downstream effects that differ by tissue. GLP-1 receptor signaling influences appetite regulation and insulin secretion in a glucose-dependent manner. GIP receptor activity contributes to metabolic handling of nutrients and may modulate adipose tissue. Glucagon receptor engagement raises energy expenditure and promotes hepatic lipid turnover, though the balance among these actions in humans is still being characterized. Preclinical models showed reductions in body weight and improved glycemic markers.
Clinical development has progressed through phase 2 trials in adults with obesity and type 2 diabetes, with phase 3 programs reported as ongoing. Reported outcomes include reductions in body weight and improvements in glycemic measures over defined treatment periods. Whether these effects translate into durable benefits after treatment ends remains an open question. Long-term safety data across broad populations are not yet complete, and regulatory decisions have not been announced.
Retatrutide is an investigational synthetic peptide engineered to activate three distinct hormone receptors within a single molecule. It targets the glucose-dependent insulinotropic polypeptide receptor, the glucagon-like peptide-1 receptor, and the glucagon receptor simultaneously. This triagonist design distinguishes it from earlier incretin-based compounds that act on one or two of these pathways. Structural modifications relative to native gut hormones extend its residence time in circulation. The molecule remains under clinical evaluation and is not approved for any indication.
Several questions remain unresolved. It is not yet known whether the compound reduces cardiovascular events or mortality, because outcome studies require long follow-up. The durability of weight reduction after treatment withdrawal is uncertain, and rebound has been observed with other incretin-based therapies. Long-term safety data covering several years are limited. Effects in adolescents, in pregnancy, and in people with significant kidney or liver impairment have not been characterized in published reports.
Randomized studies of retatrutide measure change in body weight as a percentage of baseline, along with absolute weight loss. Glycemic endpoints include hemoglobin A1c and fasting plasma glucose. Investigators also track blood pressure, lipid fractions, and liver fat content to characterize effects beyond weight alone. Trial designs typically use double-blind, placebo-controlled groups with periodic dose escalation, and they record adverse events throughout both treatment and follow-up periods.
Quantification of the peptide in biological samples generally relies on liquid chromatography coupled with tandem mass spectrometry. This approach separates the analyte from matrix components and detects it by mass-to-charge transitions specific to the molecule. Immunoassays offer higher throughput but can cross-react with related peptides and metabolites, so mass spectrometric methods are preferred when structural confirmation is required. Method validation typically addresses accuracy, precision, selectivity, and stability under handling conditions.
| Property | Value | Notes |
|---|---|---|
| Receptor targets | GIP, GLP-1, glucagon | One molecule activates all three pathways |
| Research identifier | LY3437943 | Code used in published trial reports |
| Development stage | Phase 3, reported as ongoing | Not approved by any regulatory agency |
| Route studied | Subcutaneous | Administration form used in clinical trials |
| Studied populations | Adults with obesity or type 2 diabetes | Enrollment criteria vary between trials |
Clinical studies have reported notable reductions in body weight among participants. Early trials measured safety and explored several dose levels, and later studies tracked body-weight change over months of treatment. Investigators also monitor effects on glycemic markers, liver fat, and blood lipids. Because the compound is still in development, questions about long-term safety, cardiovascular outcomes, and durability after treatment ends remain open.
The three-receptor design places retatrutide in a distinct category relative to older incretin-based therapies. Single agonists target one receptor, and dual agonists target two. Adding a third target broadens the pharmacological footprint and introduces new trade-offs among efficacy, tolerability, and glucose control. How these trade-offs resolve in large trials is a central focus of current research.
Verification of research-grade material depends on documentation supplied with a sample. A certificate of analysis lists purity, identity, and the methods used to establish each value. Buyers comparing suppliers look at chromatographic purity figures, mass confirmation data, and whether methods are described in enough detail to be reproduced. Independent testing can confirm reported values but adds cost and time. Because the research chemical market is not uniformly regulated, provenance and documentation quality vary widely, and claims should be evaluated against raw data rather than summary labels.
Characterization of retatrutide in research settings relies on reversed-phase high-performance liquid chromatography and mass spectrometry. Reversed-phase separation resolves the parent peptide from related impurities, while electrospray ionization mass spectrometry confirms molecular mass against a calculated value. Peptide mapping after enzymatic digestion can verify the amino acid sequence. Laboratories often combine orthogonal methods because no single technique establishes both identity and purity. Detected impurities typically include truncated sequences, oxidized residues, and deamidated forms that arise during synthesis or storage.
与仅靶向单一受体的同类药物相比，瑞他鲁肽增加胰高血糖素受体成分，理论上可提高能量消耗并改变脂肪分布。临床中观察到的体重变化是否主要来自该额外机制，目前尚无定论。胃肠道反应是该类药物常见不良事件，试验中通过剂量递增和监测进行管理。停药后体重反弹、个体差异和长期耐受性仍需更多数据。
瑞他鲁肽是一种在研合成肽，同时作用于胰高血糖素样肽-1、葡萄糖依赖性促胰岛素多肽和胰高血糖素受体。该分子属于多受体激动剂类别，尚未获得任何监管机构的上市批准。当前临床开发主要针对肥胖和2型糖尿病，研究代号为LY3437943。已确立的信息包括受体靶点和部分中期试验结果；最终疗效、长期安全性和适用人群仍属开放问题。
Everyone always asks if that is Demri Parrott on the Dirt Cover. I think Demri's name might have been mentioned as a possible model once or twice, but it was never a serious consideration. In an interview with the Canadian magazine M.E.A.T. in December 1992, Layne Staley said about the cover:
== Production == Phage display libraries of 109 randomized sequences are used to screen for Affimer proteins that exhibit high-specificity binding to the target protein with binding affinities in the nM range. The ability to direct in vitro screening techniques allows the identification of specific, high affinity Affimers. In vitro screening and development also mean that the target space for Affimers is not limited by the animal immune system. Affimers are generated using recombinant systems, so their generation is more rapid and reproducible compared to the production of polyclonal antibodies. Multimeric forms Affimers have been generated and shown to yield titres in the range of 200–400 mg/L under small-scale culture using bacterial host systems. Multimeric forms of Affimers with the same target specificity provide avidity effects in target binding. Many different tags and fusion proteins, such as fluorophores, single-stranded DNA, His, and c-Myc tags can be conjugated to Affimers. Specific cysteine residues can be introduced to the protein to allow thiol chemistry to uniformly orient Affimers on a solid support eg ELISA plates. This flexible functionalisation of the Affimer molecule allows functionality across multiple applications and assay formats.
== Mechanism of action == Gliotoxin is suspected to be an important virulence factor (aka pathogenicity factor) in Aspergillus fungus. Gliotoxin possesses immunosuppressive properties that may suppress and cause apoptosis in certain cells of the immune system, including neutrophils, eosinophils, granulocytes, macrophages, and thymocytes. Specifically, neutrophils exposed to gliotoxin release less reactive oxygen species (ROS) and complete fewer phagocytic activities. Gliotoxin is also believed to interfere with T-cell activation. Additionally, gliotoxin acts as an inhibitor of farnesyl transferase. It noncompetitively inhibits the chymotrypsin-like activity of the 20S proteasome. In vivo gliotoxin displays anti-inflammatory activity. It was investigated as an antibiotic and antifungal in the 1940s and as an antiviral agent. Gliotoxin inactivates many different enzymes, including nuclear factor-κB (NF-κB), NADPH oxidase, and glutaredoxin. The inhibition of NF-κB leads prevents cytokine release and induction of the inflammatory response. The immunosuppressive properties of gliotoxin are due to the disulfide bridge within its structure. Interactions occur between sulfur molecules that make up the disulfide bridge and thiol groups contained in cysteine residues. Gliotoxin acts by blocking thiol residues in the cell membrane. Gliotoxin also activates a member of the Bcl-2 family called Bak in order to mediate cell apoptosis. Activated Bak then causes the release of ROS, which form pores within the mitochondrial membrane.
Alexander, Crown Prince of Yugoslavia (Serbian: Александар Карађорђевић, Престолонаследник Југославије, romanized: Aleksandar Karađorđević, Prestolonaslednik Jugoslavije; born 17 July 1945), is the head of the House of Karađorđević, the former royal house of the defunct Kingdom of Yugoslavia and its predecessor the Kingdom of Serbia. Alexander is the only child of King Peter II and Princess Alexandra of Greece and Denmark. He held the position of crown prince in the Democratic Federal Yugoslavia for the first four-and-a-half months of his life, until the declaration of the Federal People's Republic of Yugoslavia later in November 1945, when the monarchy was abolished. In public he claims the crowned royal title of "Alexander II Karadjordjevic" (Serbian: Александар II Карађорђевић, Aleksandar II Karađorđević) as a pretender to the throne. Born and raised in the United Kingdom, he enjoys close relationships with his relatives in the British royal family. His godparents were King George VI of the United Kingdom and his daughter, the then-Princess Elizabeth (later Queen Elizabeth II). Through his father, Alexander is a descendant of Queen Victoria, through his great-great-grandfather Prince Alfred, Duke of Saxe-Coburg and Gotha, Victoria's second eldest son. Maternally, he is also a descendant of Queen Victoria, through his great-great-grandmother Victoria, German Empress, Victoria's eldest daughter. Alexander is known for his support of constitutional monarchism and his humanitarian work.
The control of enzymatic browning has always been a challenge for the food industry. A variety of approaches are used to prevent or slow down enzymatic browning of foods, each method aimed at targeting specific steps of the chemical reaction. The different types of enzymatic browning control can be classified into two large groups: physical and chemical. Usually, multiple methods are used. The use of sulfites (powerful anti-browning chemicals) have been reconsidered due to the potential hazards that it causes along with its activity. Much research has been conducted regarding the exact types of control mechanisms that take place when confronted with the enzymatic process. Besides prevention, control over browning also includes measures intended to recover the food color after its browning. For instance, ion exchange filtration or ultrafiltration can be used in winemaking to remove the brown color sediments in the solution.
Sources: en.wikipedia.org
Cocaine can induce tolerance after a single dose, and repeated use frequently leads to the development of addiction and prolonged craving. Assessment tools like the Obsessive Compulsive Cocaine Use Scale (OCCUS) may be employed to quantify obsessive and compulsive thoughts related to cocaine consumption. Withdrawal symptoms include disrupted sleep, irritability, depression, and reduced ability to experience pleasure (anhedonia). Chronic nasal use may cause destructive damage to the nasal septum, including cocaine-induced midline destructive lesions (CIMDL). Illicit cocaine is frequently adulterated with substances such as fentanyl, levamisole, or local anesthetics, increasing its toxicity. Concurrent use with alcohol produces cocaethylene, a metabolite that significantly increases the risk of sudden death. According to the Global Burden of Disease Study, cocaine use is responsible for approximately 7,300 deaths annually. Cocaine abuse can trigger addiction-related structural neuroplasticity in the human brain, although the permanence of such changes remains uncertain. Family history is a known risk factor, as relatives of cocaine users have an increased likelihood of developing cocaine addiction. A key mechanism involves the overexpression of ΔFosB in the nucleus accumbens, altering transcriptional regulation and reinforcing drug-seeking behavior. Each dose of cocaine raises ΔFosB levels without a known saturation point.
In 2004, Eurogentec opened its new production laboratories (Oligonucleotides and peptides synthesis) in the Liege Science PARK (Belgium). This intelligent building is also ecological: the building is equipped with a home automation system (lighting without switch) and the heating is produced from a condensation boiler allowing energy savings. From 2000 to 2008 Eurogentec intensified its services and signed agreements with several companies like Cepheid, Epoch Biosciences, Exiqon, Delphi, In Cell Art. 2007: In order to fully meet the Oligonucleotide in vitro diagnostics stringent manufacturing requirements, Eurogentec expanded its current GMP facility in Liège. In 2008, Eurogentec received ISO 13485 Certification for the production and sales of In Vitro Diagnostics (IVD) oligonucleotides in Liège. Two years after EGT NA also received ISO 13485 certification for the Oligonucleotide diagnostics manufacturing.
(i) Opium, opiates, derivatives of opium and opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation. Such a term does not include the isoquinoline alkaloids of opium. (ii) Poppy straw and concentrate of poppy straw. (iii) Coca leaves, except coca leaves and extracts of coca leaves from which cocaine, ecgonine and derivatives of ecgonine or their salts have been removed. (iv) Cocaine, its salts, optical and geometric isomers, and salts of isomers. (v) Ecgonine, its derivatives, their salts, isomers, and salts of isomers. (vi) Any compound, mixture, or preparation which contains any quantity of any of the substances referred to in paragraphs (b)(31)(i) through (v) of this section.
== Contraindications == The varicella vaccine is not recommended for seriously ill people, pregnant women, people who have tuberculosis, people who have experienced a serious allergic reaction to the varicella vaccine in the past, people who are allergic to gelatin, people allergic to neomycin, people receiving high doses of steroids, people receiving treatment for cancer with x-rays or chemotherapy, as well as people who have received blood products or transfusions during the past five months. Additionally, the varicella vaccine is not recommended for people who are taking salicylates (e.g. aspirin). After receiving the varicella vaccine, the use of salicylates should be avoided for at least six weeks. The varicella vaccine is also not recommended for individuals who have received a live vaccine in the last four weeks, because live vaccines that are administered too soon within one another may not be as effective. It may be usable in people with HIV infections who have a good blood count and are receiving appropriate treatment. Specific antiviral medication, such as acyclovir, famciclovir, or valacyclovir, are not recommended 24 hours before and 14 days after vaccination.
Sources: en.wikipedia.org
On 18 July 1966, the ICJ ruled that it had no authority to decide on the South West African affair. Furthermore, the court found that while Ethiopia and Liberia had locus standi to institute proceedings on the matter, neither had enough vested legal interest in South West Africa to entitle them to a judgement of merits. This ruling was met with great indignation by SWAPO and the OAU. SWAPO officials immediately issued a statement from Dar es Salaam declaring that they now had "no alternative but to rise in arms" and "cross rivers of blood" in their march towards freedom. Upon receiving the news, SWALA escalated its insurgency. Its third group, which had infiltrated Ovamboland in July, attacked white-owned farms, traditional Ovambo leaders perceived as South African agents, and a border post. The guerrillas set up camp at Omugulugwombashe, one of five potential bases identified by SWALA's initial reconnaissance team as appropriate sites to train future recruits. Here, they drilled up to thirty local volunteers between September 1965 and August 1966. South African intelligence became aware of the camp by mid 1966 and identified its general location. On 26 August 1966, the first major clash of the conflict took place when South African paratroops and paramilitary police units executed Operation Blouwildebees to capture or kill the insurgents. SWALA had dug trenches around Omugulugwombashe for defensive purposes, but was taken by surprise and most of the insurgents quickly overpowered. SWALA suffered 2 dead, 1 wounded, and 8 captured; the South Africans suffered no casualties.
=== Oral vaccines === Notable developments in vaccine delivery technologies have included oral vaccines. Early attempts to apply oral vaccines showed varying degrees of promise, beginning early in the 20th century, at a time when the very possibility of an effective oral antibacterial vaccine was controversial. By the 1930s there was increasing interest in the prophylactic value of an oral typhoid fever vaccine for example. An oral polio vaccine turned out to be effective when vaccinations were administered by volunteer staff without formal training; the results also demonstrated increased ease and efficiency of administering the vaccines. Effective oral vaccines have many advantages; for example, there is no risk of blood contamination. Vaccines intended for oral administration need not be liquid, and as solids, they commonly are more stable and less prone to damage or spoilage by freezing in transport and storage. Such stability reduces the need for a "cold chain": the resources required to keep vaccines within a restricted temperature range from the manufacturing stage to the point of administration, which, in turn, may decrease costs of vaccines.
On 9 October 2008, in an attempt to control the damage to Chinese dairy exports, officials at a World Trade Organization meeting insisted that contamination had been "accidental", directly contradicting the WHO observations. Chinese trade representatives criticised countries which have imposed blanket bans on Chinese food products. They urged member states to base import restrictions on scientific risk assessments, and to use official WTO notification mechanisms. On 11 October, Deputy Health minister Liu Qian stated that all the foreign companies' application for compensation for dairy products recall would be dealt with on a commercial basis, although government may use diplomatic channels if necessary, if problems were encountered.
Buck O'Neil and the Negro Leagues Baseball Museum presented Helton with the Walter Fenner "Buck" Leonard Legacy Award. Helton was also given the team-honored version of the Roberto Clemente Award, for his community contributions to eastern Tennessee. Furthermore, he was the NL winner of the second annual Hank Aaron Award. Each season from 2000 to 2003, he was named the Rockies Player of the Year. Capitalizing on his success, Helton signed a nine-year, $141.5 million contract in April 2001, which took effect after his then-contract expired after 2002. That season, Helton hit a career-high 49 home runs (22 of them occurred away from hitter-friendly Coors Field). He tied Walker for the most home runs ever by a Rockies player in one season. Additionally, Helton had a .336/.432/.685 slash line. He had 105 extra base hits, making him the first player in MLB history to have at least 100 total extra base hits in back-to-back seasons. Furthermore, Helton attained 402 total bases, making him only the fourth player in MLB history to do so in consecutive seasons (Chuck Klein, Gehrig and Foxx are the others). Helton appeared in his second consecutive All-Star Game in 2001 — his first as a starter. He won his first Gold Glove at first base and was once again a top candidate for MVP, but was beaten in balloting by Sammy Sosa and Barry Bonds. In 2002, Helton had a .329 batting average, 30 home runs, 109 RBI, 98 walks, 107 runs, .577 SLG and 319 total bases. He became the first player in Rockies history to score at least 100 runs in four consecutive seasons.
A TTP insurgent was killed in a military operation in North Waziristan while a woman was injured in a grenade attack in South Waziristan. Mullah Khel tribesmen repelled militants infiltrating into the village of Maulana Zeenatullah Badan in Orakzai District. A quadcopter attack in South Waziristan killed three civilians and wounded four, two more were injured in a separate quadcopter attack there while three were injured in a quadcopter attack in Bannu District. Pakistan initiated "Operation Shaban" in Balochistan. On 6 July, clashes between Pakistani and Afghan forces continued in Khyber District while nine dead bodies of tribesmen were recovered from Quetta District following a strike by 30-40 TTP insurgents on a meeting of what they claimed to be military collaborators. On 7 July, TTP militants attacked a police post in Ziarat District killing nine Policemen including two SHOs whereas 15 militants were killed in retaliatory clearance operations, several policemen were also captured by the TTP of which eighteen were later executed. CPEC brigde in Bannu District was destroyed by insurgents. An ATF personnel was killed in a skirmish with TTP in Quetta. A quadcopter strike in Bannu District killed one civilian and wounded four others. TTP captured a Pakistani joint post in Harnai District seizing weapons, equipment and vehicles.
Sources: en.wikipedia.org
It is a synthetic peptide triagonist that engages GIP, GLP-1, and glucagon receptors. Investigational compounds in this class are studied for metabolic conditions rather than for a single organ system.
No regulatory agency has approved it for any indication. It remains an investigational product studied within controlled clinical trial programs.
A dual agonist engages two receptor targets, typically GIP and GLP-1. A triagonist adds glucagon receptor activity, which is intended to influence energy expenditure alongside appetite and glucose handling.
Trials measure percentage change in body weight, absolute weight loss, and glycemic markers such as hemoglobin A1c. They also record blood pressure, lipids, and liver fat. Adverse events are tracked throughout.